Patents by Inventor Jörg GRIES

Jörg GRIES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220356194
    Abstract: A process for preparing the benzothiophen-2-yl boronate of formula (VI) which serves as an intermediate for production of medicaments and for production of medicaments for treatment and/or prophylaxis of proliferative disorders, such as cancer and tumor diseases.
    Type: Application
    Filed: March 10, 2022
    Publication date: November 10, 2022
    Applicant: Bayer Pharma Aktiengesellschaft
    Inventors: Jörg GRIES, Johannes PLATZEK
  • Publication number: 20220098201
    Abstract: Compound (III) which is the crystalline form of [4-{[4-amino-6-(methoxymethyl)-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)pyrrolo[2, -f] [1,2,4]triazin-7-yl]methyl}piperazin-2-one hydrochloride] which is the monohydrate, processes for its preparation, pharmaceutical compositions comprising it and its use in the control of disorders, including cancer.
    Type: Application
    Filed: January 27, 2020
    Publication date: March 31, 2022
    Applicants: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft
    Inventors: Jörg GRIES, Johannes PLATZEK, Claus-Christian HÄSELHOFF, Kai LOVIS
  • Publication number: 20200339606
    Abstract: A process for preparing the benzothiophen-2-yl boronate of formula (VI) which serves as an intermediate for production of medicaments and for production of medicaments for treatment and/or prophylaxis of proliferative disorders, such as cancer and tumor diseases.
    Type: Application
    Filed: October 18, 2018
    Publication date: October 29, 2020
    Applicant: Bayer Pharma Aktiengesellschaft
    Inventors: Jörg GRIES, Johannes PLATZEK
  • Publication number: 20120129857
    Abstract: The present application relates to sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1 H-pyrazol-5-olate, to processes for its preparation, to its use for the treatment and/or prophylaxis of diseases and to its use for the preparation of medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular and haematological diseases and kidney diseases, and for promoting wound healing.
    Type: Application
    Filed: November 8, 2011
    Publication date: May 24, 2012
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Hans-Christian MILITZER, Jörg GRIES, Stefan KOEP